申请人:Reiser Ulrich
公开号:US20090258857A1
公开(公告)日:2009-10-15
The present invention encompasses compounds of general formula (1) wherein R
1
, M
1
, L
1
and Q are defined as in claim
1
, which are suitable for the treatment of diseases characterised by excessive or anomalous cell proliferation, and the use thereof for preparing a pharmaceutical composition with the above-mentioned properties.